Alok Srivastava, Professor - Research  and Head, Haematology Research Unit St. Johns Research Institute, St, John’s Hospital, Bangalore.

Prof. Srivastava has been involved with haematopoietic stem cell transplantation (HSCT) in India for more than three decades at CMC Vellore. He is the immediate past President of the Indian Society for Blood and Marrow Transplant and the current Chairman of the Executive Board of the Asia Pacific Blood and Marrow Transplant Group. He was the first Chair of the National Apex Committee for Stem Cell Research and Therapy of the Department of Health Research in the Ministry of Health of the Government of India during 2010-2016. He has recently conducted the first human clinical trial of gene therapy for severe haemophilia A in India using blood stem cells.